Recruiting
Acute myeloid leukaemia
RecruitingTambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles
Registered drugNo placebo
Tambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles
Registered drugNo placebo
- Disease:Acute myeloid leukaemia
- Substances:AzacitidineTambiciclib+1
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Azacitidine

